|Bid||50.16 x 800|
|Ask||50.21 x 800|
|Day's range||49.69 - 51.15|
|52-week range||18.09 - 68.94|
|Beta (5Y monthly)||2.12|
|PE ratio (TTM)||275.08|
|Earnings date||03 Nov 2021 - 08 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||64.88|
If the last few weeks have you wondering whether a bear market is on the horizon, you're not alone. In fact, for biotechs without any products that are approved for sale, a bear market can be a great opportunity to pick up a few shares at a discount. Let's explore why -- and also why there are other biotechs that you might want to be warier of when prices are trending lower.
With its stock down 13% over the past month, it is easy to disregard Vericel (NASDAQ:VCEL). However, the company's...
S&P, NASDAQ Begin Week with Another Session of Record Highs